St. Louis, MO, United States of America

Michael S South

This inventor holds 32 USPTO granted patents, primarily in Pharmaceutical Chemistry. Top assignees: Pharmacia Corporation, Monsanto Company, G.d. Searle & Company. Active years: 1996-2006.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Michael S South. Retrieved from https://idiyas.com/inventor/michael-s-south

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 43.8

Average Co-Inventor Count = 4.0

ph-index = 8

Forward Citations = 260(Granted Patents)


Company Filing History:


Years Active: 1996-2006

Loading Chart...
Areas of Expertise:
p38 Kinase Inhibitors
Anticoagulants
Polycyclic Compounds
Pyrazoles
Heterocyclic Compounds
Herbicidal Compositions
Pyridones
Triazinones
Uracils
Pyrazinones
Pyrimidinones
Phenylpyridazines
32 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Michael S. South in Patent Development

Introduction: Michael S. South is an accomplished inventor based in St. Louis, MO, known for his significant contributions to the field of pharmaceutical sciences. With an impressive portfolio of 32 patents, he has made notable advancements in the treatment of various medical conditions through innovative compounds.

Latest Patents: Among his latest patents, Michael has developed "Substituted Pyrazoles as p38 Kinase Inhibitors." This class of pyrazole derivatives is designed for treating disorders mediated by p38 kinase, showcasing his expertise in targeted therapeutic interventions. Another noteworthy invention is the "Substituted Polycyclic Aryl and Heteroaryl Pyrazinones," which are valuable as selective inhibitors of serine proteases within the coagulation cascade. This invention holds promise for anticoagulant therapy, potentially aiding in the treatment and prevention of thrombotic conditions such as coronary artery and cerebrovascular diseases.

Career Highlights: Michael's professional journey includes pivotal roles at renowned companies. He has contributed his innovative skills at Pharmacia Corporation and Monsanto Company, where he has been instrumental in developing new pharmaceutical solutions that bring real-world benefits to patients.

Collaborations: Michael’s work has been enhanced through collaborations with accomplished professionals such as Melvin L. Rueppel and Darin E. Jones. These partnerships have fostered an environment of creativity and innovation, leading to successful patent applications in their respective research areas.

Conclusion: Michael S. South exemplifies the spirit of innovation in medicine, with a robust patent portfolio marking his contributions to healthcare. His work not only reflects his dedication as an inventor but also underscores the importance of collaborative efforts in advancing therapeutic solutions for complex medical challenges.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…